Contract Development and Manufacturing Organizaton (CDMO)
Our integrated R&D and manufacturing platform forms an integral part of Mithra’s innovation and development strategy
Mithra CDMO is an open platform that operates as a unique pharmaceutical ecosystem covering drug development from proof of concept to commercialization.
It will support third parties willing to leverage our technological know-how and capabilities for the R&D and manufacturing of polymeric forms (intra-uterine systems, biocompatible rings, implants, (hydro)gels, sterile injectables (vials, ready-to-use cartridges, prefilled syringes) and hormonal tablets.
Mithra CDMO offers an integrated approach to pharmaceutical drug development : development, clinical supply manufacturing, stability studies, contract manufacturing, logistics & supply chain, quality assurance and regulatory services.
Stages of construction
2014 – 2016
- R&D facility and production lines for polymeric forms, implants and sterile injectables
- Inaugurated on September 30th, 2016
2017 – 2019
- Production line for tablets (e.g. Estelle® and Donesta®)